E-LIB Suche - Ergebnisse für: Conlan, G.

1

Influence of drill type and unit fitting on accelerometer d..:

Cummins, C. ; McLean, B. ; Conlan, G..
Journal of Science and Medicine in Sport. 20 (2017) - p. e117-e118 , 2017

Link: https://doi.org/10.1016/..

2

A Phase II Trial of Rivoceranib, an Oral Vascular Endotheli..:

Hanna, Glenn J. ; Ahn, Myung-Ju ; Muzaffar, Jameel...
Clinical Cancer Research. 29 (2023) 22 - p. 4555-4563 , 2023

Link: https://doi.org/10.1158/..

3

A First-in-Human Phase 1 Study of a Novel Selective Androge..:

LoRusso, Patricia ; Hamilton, Erika ; Ma, Cynthia...
Clinical Breast Cancer. 22 (2022) 1 - p. 67-77 , 2022

Link: https://doi.org/10.1016/..

4

A phase 1b study evaluating the effect of elacestrant treat..:

Jager, Agnes ; de Vries, Elisabeth G. E. ; der Houven van Oordt, C. Willemien Menke-van...
Breast Cancer Research. 22 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..

5

Pharmacokinetic and Pharmacodynamic Studies of Elacestrant,..:

Conlan, Maureen G. ; de Vries, Erik F. J. ; Glaudemans, AWJM..
European Journal of Drug Metabolism and Pharmacokinetics. 45 (2020) 5 - p. 675-689 , 2020

Link: https://doi.org/10.1007/..

6

Correction to: Pharmacokinetic and Pharmacodynamic Studies ..:

Conlan, Maureen G. ; de Vries, Erik F. J. ; Glaudemans, AWJM..
European Journal of Drug Metabolism and Pharmacokinetics. 45 (2020) 5 - p. 691-692 , 2020

Link: https://doi.org/10.1007/..

7

EMERALD: Phase III Trial of Elacestrant (RAD1901) vs Endocr..:

Bardia, Aditya ; Aftimos, Philippe ; Bihani, Teeru...
Future Oncology. 15 (2019) 28 - p. 3209-3218 , 2019

Link: https://doi.org/10.2217/..

8

Factors influencing long‐term efficacy and tolerability of ..:

Brümmendorf, Tim H. ; Cortes, Jorge E. ; Khoury, Hanna J....
British Journal of Haematology. 172 (2015) 1 - p. 97-110 , 2015

Link: https://doi.org/10.1111/..

9

3061 Assessment of Brigatinib (AP26113) CNS Activity in Pat..:

Camidge, D.R. ; Bazhenova, L.A. ; Salgia, R....
European Journal of Cancer. 51 (2015) - p. S616 , 2015

Link: https://doi.org/10.1016/..

10

Long-term Results of Ponatinib in CP-CML: 4-Year Minimum Fo..:

Kantarjian, Hagop M. ; Talpaz, Moshe ; Cortes, Jorge E....
Clinical Lymphoma Myeloma and Leukemia. 15 (2015) - p. S35 , 2015

Link: https://doi.org/10.1016/..

11

A pediatric phase I trial and pharmacokinetic study of ispi..:

Souid, Abdul‐Kader ; Dubowy, Ronald L. ; Ingle, Ashish M....
Pediatric Blood & Cancer. 55 (2010) 7 - p. 1323-1328 , 2010

Link: https://doi.org/10.1002/..

12

The above letter was sent to Slichter et al.; Drs Slichter ..:

Slichter, Sherrill J. ; Raife, Thomas J. ; Davis, Kathryn...
Transfusion. 46 (2006) 12 - p. 2211-2212 , 2006

Link: https://doi.org/10.1111/..

13

Therapeutic efficacy and safety of photochemically treated ..:

Janetzko, Karin ; Cazenave, Jean‐Pierre ; Klüter, Harald...
Transfusion. 45 (2005) 9 - p. 1443-1452 , 2005

Link: https://doi.org/10.1111/..

14

Amotosalen interactions with platelet and plasma components..:

Lin, Lily ; Conlan, Maureen G. ; Tessman, John..
Transfusion. 45 (2005) 10 - p. 1610-1620 , 2005

Link: https://doi.org/10.1111/..

15

Therapeutic efficacy and safety of red blood cells treated ..:

Benjamin, Richard J. ; McCullough, Jeffrey ; Mintz, Paul D....
Transfusion. 45 (2005) 11 - p. 1739-1749 , 2005

Link: https://doi.org/10.1111/..